Navigation Links
Lilly Reports Second-Quarter 2011 Results
Date:7/21/2011

many of our marketed products, as well as important investments we are making to expand our commercial opportunities and deliver the next wave of potential new medicines to patients," said John C. Lechleiter, Ph.D., Lilly's chairman, president and chief executive officer. "Key Lilly products continue to perform well, including Cymbalta, Cialis and our insulins. Exchange rates have also contributed to favorable sales comparisons. At the same time, we are investing for the company's future by supporting the launches of new medicines and new indications, as well as funding our R&D pipeline, which now boasts 70 potential new medicines in clinical development."

Key Events Over the Last Three Months

  • The U.S. Food and Drug Administration (FDA) approved Tradjenta™ (linagliptin), a prescription medication used along with diet and exercise to lower blood sugar in adults with type 2 diabetes. The company, along with its partner Boehringer Ingelheim, recently launched Tradjenta in the United States. Linagliptin was also approved in Japan, Mexico and Brazil and received a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP).
  • The European Commission granted marketing authorization to Bydureon™, the first once-weekly treatment for type 2 diabetes. The company is developing Bydureon along with its partners, Amylin Pharmaceuticals and Alkermes, Inc.
  • The company filed for a new indication with the FDA for Erbitux® in first-line non-small cell lung cancer.
  • The U.S. District Court for the Southern District of Indiana issued an order that prohibits the remaining defendants in the Cymbalta® patent litigation from selling a generic duloxetine product in the United States during the term of the Cymbalta compound patent. The patent provides protection for Cymbalta until at least June of 2013.  
  • The company signed agreements with private investors Care Capit
    '/>"/>

  • SOURCE Eli Lilly and Company
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

    Related medicine technology :

    1. Lilly Presents Follow-Up Data on Semagacestat to Assist Future Alzheimers Disease Research
    2. Lilly and Argonne National Laboratory Announce $2 Million Upgrade to Lillys Beamline Capabilities
    3. Lilly Donation to Patient Advocate Foundation Expands Services and Access for Patients With Most Common Form of Lung Cancer
    4. Lilly CEO Says Biopharmaceuticals Should Be Included in Transatlantic Trade and Economic Discussions
    5. Lilly CEO Calls for Improved Dialogue in Germany Between Industry and the Government and Health Care System
    6. Lilly Quality Leader Walsh Appointed to Companys Executive Committee
    7. Lilly Outlines For Investors How Its Innovation-Based Strategy and Robust Pipeline Will Drive Future Growth Following Upcoming Patent Expirations
    8. Lilly Announces New Investment to Further Boost Its Biotechnology Capabilities
    9. Lilly Declares Third-Quarter 2011 Dividend
    10. Lilly for Better Health™ Launches Enhanced Multi-Channel Patient Education Platform
    11. Synthes and Lilly Sign Development and Collaboration Agreement
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/27/2015)... -- RnRMarketResearch.com adds "Visceral Pain - ... of 52 pages with latest updates, data and ... The report "Visceral Pain - Pipeline Review, H1 2015" ... Visceral Pain, complete with comparative analysis at various ... action (MoA), route of administration (RoA) and molecule ...
    (Date:3/27/2015)... 27, 2015  WebMD Health Corp. (NASDAQ: ... health information, today announced an exclusive White ... Action Plan for Combating Antibiotic-Resistant Bacteria . ... urgency and importance of addressing antibiotic-resistant bacteria ... health.    The WebMD interview, available ...
    (Date:3/26/2015)... PASADENA, Calif. , March 26, 2015 ... San Gabriel Valley to perform transcatheter aortic valve replacement ... TAVR procedure is a revolutionary new way to replace ... use of a heart lung machine. The ... heart team led by Azhil ( Alex) Durairaj , ...
    Breaking Medicine Technology:Visceral Pain Pipeline Review H1 2015 Market Research Report 2Visceral Pain Pipeline Review H1 2015 Market Research Report 3Visceral Pain Pipeline Review H1 2015 Market Research Report 4Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 2Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 3Huntington Memorial Hospital Performs Groundbreaking Minimally Invasive Replacement of Heart Valves 2
    ... , June 18 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: ... announced today that it,will hold its 2010 Annual Meeting of Shareholders ... Beijing Time. The meeting will be held concurrently at No. 39,Shangdi ... 6 Temple Street, St.,John,s, Antigua . All shareholders of record ...
    ... The chairman of the U.S. bishops, Committee on Pro-Life Activities ... over its move toward approving a new drug that may induce ... letter to Dr. Margaret Hamburg , Commissioner of the ... criticized the FDA,s move to hold an advisory committee meeting ...
    Cached Medicine Technology:Sinovac Schedules 2010 Annual Meeting of Shareholders 2Sinovac Schedules 2010 Annual Meeting of Shareholders 3Pro-Life Chair Voices 'Grave Concern' over FDA Plan to Approve Abortion Drug for 'Emergency Contraception' 2Pro-Life Chair Voices 'Grave Concern' over FDA Plan to Approve Abortion Drug for 'Emergency Contraception' 3Pro-Life Chair Voices 'Grave Concern' over FDA Plan to Approve Abortion Drug for 'Emergency Contraception' 4
    (Date:3/28/2015)... AZ. (PRWEB) March 28, 2015 Could ... to a new study by researchers at ... , Produced with the support of the Coffee and ... journal Molecular Psychiatry this past fall, the study—one of ... meta-analysis of genomic data from more than 120,000 regular ...
    (Date:3/28/2015)... With more than 4,500 scientists, clinicians ... osteoarthritis and musculoskeletal diseases gathered here for the ... first time in the 17-year history of the ... topic is an emerging non-pharmaceutical protocol for enhancing ... of Wolff’s law, osteogenic loading at multiples of ...
    (Date:3/28/2015)... 2015 Emergency Medical Care (EMC), a ... Manhattan, recently commemorated its three-year anniversary of being the ... addition to 24-hour urgent care, Emergency Medical Care offers ... this time, Emergency Medical Care’s Urgent Care NYC ... pain, eye injuries, ear infections, fevers, insect bites, burns, ...
    (Date:3/28/2015)... 2015 Centurion Service Group will be hosting ... April 2 at their Las Vegas warehouse, located at 4606 ... sale, which consists of equipment from hospitals and surgery centers ... a.m. PDT. , Buyers will find items of all ... are a one-stop-shop,” said Erik Tivin, CEO of Centurion. , ...
    (Date:3/28/2015)... March 28, 2015 How best to ... growing field in orthopaedic medicine. While diagnostic hip injections ... confirm the pain etiology, research presented today at the ... Specialty Day suggests that pain relief from this diagnostic ... surgery. , “Our study looked to assess if ...
    Breaking Medicine News(10 mins):Health News:How Coffee Habits Relate to Our Genetic Code and Enhancing the Caffeine Experience 2Health News:How Coffee Habits Relate to Our Genetic Code and Enhancing the Caffeine Experience 3Health News:Non-Drug Protocol for Building Bone Density Expected to Steal Spotlight at World Congress on Osteoporosis 2Health News:Emergency Medical Care Celebrates Three Years of 24/7 Walk-In Urgent Care Services 2Health News:Medical Equipment Auction to Take Place in North Las Vegas 2Health News:Pain Injections for Hip Arthroscopy Patients May Not Predict Surgical Outcomes 2
    ... Speaker Nancy Pelosi,spoke at the Congressional Gold Medal ceremony ... Dr. Michael DeBakey. Below are the,Speaker,s remarks:, "Good ... President Bush,leaders of the House and Senate to honor ... and my colleague Representative Al,Green, and others who worked ...
    ... CHAPEL HILL, N.C., April 23 Global leaders ... as a powerful tool for competing in today,s ... firm Best Practices, LLC.,The study further reveals -- ... strategic process of transforming raw competitive data,into actionable ...
    ... Glaser Pediatric AIDS Foundation (EGPAF), a world leader in ... award five grants totaling $1 million to researchers to ... , Shan Lu, MD, PhD, professor of medicine at ... Katherine Ruiz De Luzuriaga, MD, professor of pediatrics and ...
    ... New Study, FALLS CHURCH, Va. and CUMMAQUID, ... in close,association with research analysis partner Cambashi Ltd, ... new survey on current industry,challenges and practices. The ... information systems and applications, and,performance., The research ...
    ... inflammation, hints of new treatments for disease , , WEDNESDAY, ... have discovered how tumors develop in the stomach, a ... cancer. , In a study done on mice, scientists ... for Cancer Research (LICR) found that blocking the signaling ...
    ... WINSTON-SALEM, N.C., April 23 Reynolds,American Inc. (NYSE: ... of first-quarter 2008 financial results on Wednesday, April 30,2008. ... During the call, members of the Reynolds American ... conference call will be available online on a listen-only ...
    Cached Medicine News:Health News:Pelosi: 'By Literally Fixing Broken Hearts, Dr. DeBakey Has Given Hope and Health to Millions' 2Health News:Complimentary Excerpt Available from Best Practices: Pharmaceutical Competitive Intelligence Excellence - Optimizing Data Collection within Approved Guidelines 2Health News:UMass Medical School researchers awarded pediatric HIV vaccine development grant 2Health News:UMass Medical School researchers awarded pediatric HIV vaccine development grant 3Health News:Risk Management: Best Practices for Medical Device Profitability 2Health News:Scientists Discover How Stomach Tumors Form 2Health News:RAI to Webcast First Quarter 2008 Earnings Conference Call 2
    ... Kendall provides hospitals and alternate care ... tracheostomy care trays which offer the ... control. Designed with the guidance of ... trays provide exactly what is required ...
    ... Each KIMBERLY-CLARK BALLARD Component ... T-Pieces, Elbows and Double ... configurations. Customer-oriented presentation to ... sterilized. Also available in ...
    ... permanent flexible tube extension on ... neck flange helps keep connections ... and stoma, enhancing patient mobility ... FlexTend™ tracheostomy tubes improve tube ...
    ... permanent flexible tube extension on ... neck flange helps keep connections ... and stoma, enhancing patient mobility ... FlexTend™ tracheostomy tubes improve tube ...
    Medicine Products: